NIH: Hydrocortisone Does Not Prevent Lung Complication in Extremely Preterm Infants
March 24, 2022
March 24, 2022
WASHINGTON, March 24 (TNSJou) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release on March 23, 2022:
Hydrocortisone is no more effective than placebo at preventing damage that can result from oxygen and ventilator therapy necessary to keep preterm infants alive, according to research funded by the National Institutes of Health. The study of a potential treatment for the condition, known as bronchopulmonary dysplas . . .
Hydrocortisone is no more effective than placebo at preventing damage that can result from oxygen and ventilator therapy necessary to keep preterm infants alive, according to research funded by the National Institutes of Health. The study of a potential treatment for the condition, known as bronchopulmonary dysplas . . .